Market Tracker

06/30 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

8.63
Delayed Data
As of 3:59pm ET
 +0.20 / +2.37%
Today’s Change
6.96
Today|||52-Week Range
25.25
-50.20%
Year-to-Date

Today’s Trading

Previous close8.43
Today’s open8.43
Day’s range8.30 - 8.76
Volume1,279,231
Average volume (3 months)1,728,669
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-310.38%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book25.12

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.30-0.72%
MCRBSeres Therapeutics I...-0.79-2.65%
AVXSAveXis Inc-2.72-6.68%
AXONAxovant Sciences Ltd-0.09-0.70%
Data as of 4:14pm ET, 06/30/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts